Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
Condition(s):Tardive DyskinesiaLast Updated:December 19, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Tardive DyskinesiaLast Updated:December 19, 2018Completed
Condition(s):Chorea, HuntingtonLast Updated:December 31, 2020Enrolling by invitation
Condition(s):Tardive Dyskinesia (TD)Last Updated:September 11, 2019Recruiting
Condition(s):Tardive Dyskinesia (TD)Last Updated:June 4, 2020Completed
Condition(s):Chorea, HuntingtonLast Updated:December 31, 2020Recruiting
Condition(s):Tourette SyndromeLast Updated:February 17, 2020Terminated
Condition(s):Tourette SyndromeLast Updated:February 17, 2020Completed
Condition(s):Tourette SyndromeLast Updated:February 17, 2020Terminated
Condition(s):Tourette SyndromeLast Updated:March 18, 2019Completed
Condition(s):Effect of Ketoconazole on the PK of NBI-98854 in Healthy SubjectsLast Updated:September 5, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.